INSULET CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.9 USD | -6.55% |
|
-4.89% | -23.54% |
| May. 10 | Raymond James Adjusts Price Target on Insulet to $213 From $218 | MT |
| May. 10 | Wolfe Research Raises Price Target on Insulet to $205 From $200 | MT |
Presenter SpeechCecilia Furlong (Analysts)Great. Good morning, everyone. Thank you for joining...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. In addition, the group offers non-insulin subcutaneous drug delivery systems used in several therapeutic areas. Net sales break down by family of products as follows:
- Insulin pump therapy systems (95.6%): continuous insulin management and delivery systems (Omnipod® and Omnipod DASH® brands) and automated insulin administration systems (Omnipod® 5 brand);
- non-insulin drug administration systems (4.4%): in particular pre-filled syringes for the Neulasta® Onpro® kit (intended for the treatment of neutropenia in patients treated with chemotherapy).
By the end of 2022, the group will have 2 production sites located in the United States and in China.
The United States accounts for 72.2% of net sales.
Calendar
2024-05-22
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
165.9
USD
Average target price
233.5
USD
Spread / Average Target
+40.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.54% | 11.62B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Transcript : Insulet Corporation Presents at NASDAQ 47th Investor Conference, Dec-06-2022 11
